EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

AI Methods Tailored to Influenza, RSV, HIV, and SARS-CoV-2: A Focused Review

Achilleas Livieratos, George C Kagadis iD, Charalambos Gogos, Karolina Akinosoglou iD

Pathogens · 30.07.2025 · 14 (8) · 748

DOI: 10.3390/pathogens14080748 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 30.07.2025. Verfasst von Achilleas Livieratos und 3 weiteren Autor:innen. Beteiligte Einrichtung: Independent Researcher, 15238 Athens, Greece. Hauptthemen laut MEDLINE: COVID-19, Influenza, Human, HIV Infections, Artificial Intelligence. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artificial intelligence (AI) techniques—ranging from hybrid mechanistic–machine learning (ML) ensembles to gradient-boosted decision trees, support-vector machines, and deep neural networks—are transforming the management of seasonal influenza, respiratory syncytial virus (RSV), human immunodeficiency virus (HIV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Symptom-based triage models using eXtreme Gradient Boosting (XGBoost) and Random Forests, as well as imaging classifiers built on convolutional neural networks (CNNs), have improved diagnostic accuracy across respiratory infections. Transformer-based architectures and social media surveillance pipelines have enabled real-time monitoring of COVID-19. In HIV research, support-vector machines (SVMs), logistic regression, and deep neural network (DNN) frameworks advance viral-protein classification and drug-resistance mapping, accelerating antiviral and vaccine discovery. Despite these successes, persistent challenges remain—data heterogeneity, limited model interpretability, hallucinations in large language models (LLMs), and infrastructure gaps in low-resource settings. We recommend standardized open-access data pipelines and integration of explainable-AI methodologies to ensure safe, equitable deployment of AI-driven interventions in future viral-outbreak responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Influenza, HumanHIV InfectionsArtificial IntelligenceRespiratory Syncytial Virus InfectionsHumansSARS-CoV-2Neural Networks, ComputerMachine Learning

Stichwörter der Autor:innen

COVID-19HIVRSVartificial intelligenceinfluenza

Autor:innen und Institutionen

  • Independent Researcher, 15238 Athens, Greece.
  • Department of Medicine, University of Patras, 26504 Rio, Greece.
  • Metropolitan General Hospital, 15562 Athens, Greece.
  • Department of Internal Medicine and Infectious Diseases, University General Hospital of Patras, 26504 Rio, Greece.

ORCID-Profile: George C Kagadis, Karolina Akinosoglou

Zitieren

APA

Livieratos, A., Kagadis, G. C., Gogos, C., & Akinosoglou, K. (2025). AI Methods Tailored to Influenza, RSV, HIV, and SARS-CoV-2: A Focused Review. Pathogens, 14(8), 748. https://doi.org/10.3390/pathogens14080748

Vancouver

Livieratos A, Kagadis GC, Gogos C, Akinosoglou K. AI Methods Tailored to Influenza, RSV, HIV, and SARS-CoV-2: A Focused Review. Pathogens. 2025;14(8):748. doi:10.3390/pathogens14080748

BibTeX
@article{Livieratos2025,
  author = {Livieratos, Achilleas and Kagadis, George C and Gogos, Charalambos and Akinosoglou, Karolina},
  title = {AI Methods Tailored to Influenza, RSV, HIV, and SARS-CoV-2: A Focused Review},
  journal = {Pathogens},
  year = {2025},
  volume = {14},
  number = {8},
  pages = {748},
  doi = {10.3390/pathogens14080748}
}
Kostenlos starten →